Abstract
The hypothesis that the pharmacokinetics of amikacin are more predictable than those of gentamicin or tobramycin was studied.In a three-way crossover design 58 volunteers received 7.5 mg/kg amikacin by iv infusion and either 1.5 mg/kg or 1 mg/kg gentamicin and tobramycin. The mean half-life and mean serum concentration at 1 h for each drug was determined. No consistent significant difference was found between the pharmacokinetics of amikacin and the other two drugs.
Original language | English |
---|---|
Pages (from-to) | 371-376 |
Number of pages | 6 |
Journal | Journal of Antimicrobial Chemotherapy |
Volume | 12 |
Issue number | 4 |
DOIs | |
Publication status | Published - Oct 1983 |
Externally published | Yes |